Gain on sale of subsidiary - - 78,352 -
Net (loss) income from
discontinued operations - (1,092) 75,361 (1,495)
Net (loss) income ($9,898) ($15,880) $27,969 ($44,043)
Basic and diluted net loss per
share from continuing operations ($0.18) ($0.27) ($0.85) ($0.77)
Basic and diluted net (loss)
income per share from
discontinued operations - (0.02) 1.35 (0.03)
Basic and diluted net (loss)
income per share ($0.18) ($0.29) $0.50 ($0.80)
Weighted average number of shares
used in computing basic and
diluted net (loss) income per
share 55,965 54,932 55,699 54,784
SELECTED BALANCE SHEET INFORMATION
September 30, December 31,
2007 2006
(unaudited)
Cash and investments (excluding
restricted cash) $139,217 $164,393
Restricted cash 14,366 -
Working capital 147,630 95,985
Total assets 158,497 227,294
Convertible subordinated debentures 109,391 176,228
Total long-term liabilities 110,499 111,174
Accumulated deficit 485,003 512,972
Stockholders' equity 39,678 8,767
| SOURCE CuraGen Corporation Copyright©2007 PR Newswire. All rights reserved |